Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.JAMA Oncology|December 9, 2016
Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection MethodGypsyamber D'Souza, William H Westra, Steven J Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.Endocrinology|March 31, 2011
Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer developmentWoo-Young Kim, Mi-Jung Kim, Hojin Moon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.Head & Neck|June 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With PembrolizumabAngeline A Truong, Savinnie Ho, Minna K I Apostolova, et al.Journal for Immunotherapy of Cancer|February 26, 2022
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinomaRobert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2017
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer CellsHiroyuki Ozawa, Ruchira S Ranaweera, Evgeny Izumchenko, et al.British Journal of Cancer|June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.Laryngoscope Investigative Otolaryngology|March 2, 2026
Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care ContinuumNicholas Correia, Kennedy Johnson, Megan Durr, et al.Pageof 8